online games shooting
Aurora's self-driving truck tech boosts Bozeman job market
NEW YORK , Dec. 5, 2024 /PRNewswire/ -- Report with market evolution powered by AI - The clinical trials market in US size is estimated to grow by USD 5 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 4.38% during the forecast period. Rise in number of clinical trials of drugs is driving market growth, with a trend towards advancement in technology and scientific research. However, rise in cost of clinic trials poses a challenge. Key market players include Accell Clinical Research LLC, Apex Medical Research Inc., Caidya, Charles River Laboratories International Inc., Clinipace Inc., CTI Clinical Trial and Consulting Inc., Eli Lilly and Co., eResearchTechnology GmbH, ICON plc, IQVIA Holdings Inc., Laboratory Corp. Of America Holdings, Medpace Holdings Inc., Novartis AG, Novo Nordisk AS, Parexel International Corp., Pfizer Inc., Sanofi SA, Syneos Health Inc., Thermo Fisher Scientific Inc., and WuXi AppTec Co. Ltd.. AI-Powered Market Evolution Insights. Our comprehensive market report ready with the latest trends, growth opportunities, and strategic analysis- View Free Sample Report PDF Key Market Trends Fueling Growth The Clinical Trials Market in the US is experiencing significant growth, driven by biopharmaceutical and medical device companies seeking to bring new drug candidates to market. Contract Research Organizations (CROs) play a crucial role in this process, providing essential services to pharmaceutical companies during all phases of clinical research, from Phase I to IV. This includes working with healthcare workers to conduct studies on various diseases such as cardiology, autoimmune, inflammation, pain management, oncology, CNS conditions, diabetes, obesity, and cardiovascular conditions. Technological evolution is a key trend in the market, with the use of AI, IoT, real-world data, patient-centric trials, virtual trials, and home healthcare services driving digitalization. The demand for CROs is high, with companies like Parexel and Syneos Health leading the way in providing CRO services. Small-molecule drugs, biologics, biosimilars, and large-molecule drugs are all under development, with raw material suppliers and laboratory services supporting research activities. The industry is at a growth stage, with R&D programs and outsourcing activities expanding. The European Medicines Agency and other regulatory bodies are also playing a role in the market, with an increased focus on personalized medicine and advanced therapies. Patent expiration is leading to an increased focus on post-marketing surveillance. The degree of innovation is high, with big data analytics, remote monitoring, and electronic data capture driving progress. End-users include hospitals and clinics, with virtual clinical trials, interventional studies, expanded access trials, and compassionate use trials also playing a role. Industries like Thermo Fisher Scientific and CorEvitas, LLC are contributing to the market with their expertise in various areas. The clinical trials market in the US has experienced substantial progress due to technological and scientific advancements. Notable developments include the implementation of electronic data capture (EDC) systems. EDC platforms streamline and enhance clinical trial data management. Researchers can now electronically record data from study participants, eliminating the need for paper-based systems and manual data entry. This leads to time savings, reduced errors, and improved data quality. EDC systems play a crucial role in the efficient and effective testing and approval of new medications and therapies. Insights on how AI is driving innovation, efficiency, and market growth- Request Sample! The Clinical Trials Market in the US is a significant sector, involving biopharmaceutical and medical device companies, Contract Research Organizations (CROs), and various end-users like hospitals and clinics. Challenges include bringing new drug candidates, including small-molecule drugs, biologics, biosimilars, and large-molecule drugs, through Phase I, II, III, and IV trials for indications like autoimmune, inflammation, pain management, oncology, CNS conditions, diabetes, obesity, and cardiovascular diseases. Healthcare workers collaborate with CROs to conduct research activities, while raw material suppliers and laboratory services support the process. Technological evolution, including genomics, AI, IoT, real-world data, patient-centric trials, virtual trials, home healthcare services, and digitalization, is transforming the industry. End-users, including people with diseases, seek personalized medicine and innovative treatments, driving the demand for CROs and R&D programs. The industry's growth stage is influenced by outsourcing activities, patent expiration, and regulatory requirements from the European Medicines Agency and FDA. Companies like Parexel, Syneos Health, Thermo Fisher Scientific, and CorEvitas LLC contribute to the degree of innovation with electronic data capture, decentralized trials, telemedicine, and advanced therapies. The cost of clinical trials in the US has emerged as a major concern for the healthcare sector. Complexity in research protocols, stringent regulatory requirements, and the high cost of acquiring and maintaining technology and equipment are primary reasons for this increase. The demand for large-scale, multicenter trials further adds to the expenses. The intricacy of research protocols has grown as the medical field advances, necessitating extensive and detailed protocols to ensure precise data collection and analysis. Insights into how AI is reshaping industries and driving growth- Download a Sample Report This clinical trials market in US report extensively covers market segmentation by 1.1 Phase III 1.2 Phase I 1.3 Phase II 1.4 Phase IV 2.1 Interventional studies 2.2 Observational studies 2.3 Expanded access studies 3.1 Oncology 3.2 CNS 3.3 Autoimmune/inflammation 3.4 Others 4.1 North America 1.1 Phase III- The Phase III segment of clinical trials in the US plays a crucial role in testing the safety and efficacy of new drugs or medical treatments before they are approved for public use. This phase is the final step in the drug development process and involves testing the investigational treatment on a larger population to gather more data and assess potential benefits and risks. For instance, a new cancer drug that has already undergone rigorous testing in Phase I and II trials will enter Phase III trials, where it is administered to a larger group of cancer patients. The trial aims to gather more evidence on the drug's safety profile, dosage, side effects, and long-term outcomes. Phase III trials involve hundreds or even thousands of participants spread across multiple trial sites in the country. These trials are meticulously planned, ethically conducted, and require data management systems. Regulatory authorities, such as the US Food and Drug Administration (FDA), rely on the data from Phase III trials to evaluate the safety and effectiveness of new treatments and make informed decisions about their approval. The growing demand for new treatments and the increasing focus on personalized medicine are expected to drive the growth of the Phase III clinical trials market in the US during the forecast period. Download complimentary Sample Report to gain insights into AI's impact on market dynamics, emerging trends, and future opportunities- including forecast (2024-2028) and historic data (2017 - 2021) The Clinical Trials Market in the US is experiencing significant growth due to the increasing number of biopharmaceutical and medical device companies investing heavily in Research & Development (R&D) for new drug candidates and medical devices. Clinical research organizations (CROs) and laboratories play a crucial role in conducting clinical trials for these companies. The focus on patient-centric trials, virtual trials, and real-world data is transforming the clinical trials landscape. Technological advancements such as genomics, Artificial Intelligence (AI), Internet of Things (IoT), and digital health are revolutionizing the way trials are conducted. Small-molecule drugs and biologics continue to dominate the market, with Interferon-beta treatment being a notable example. The technological evolution of clinical trials is enabling faster and more efficient trial processes, benefiting both healthcare workers and patients alike. Traditional clinical trials are being supplemented with innovative approaches to address the challenges of recruiting and retaining patients, ensuring data accuracy, and reducing trial costs. The Clinical Trials Market in the US is a dynamic and evolving industry, driven by the research and development (R&D) activities of biopharmaceutical companies and medical device manufacturers. The market encompasses various stakeholders including clinical research organizations (CROs), healthcare workers, and end-users such as hospitals and clinics. The pipeline includes drug candidates ranging from small-molecule drugs to biologics and biosimilars, with a focus on indications like autoimmune, inflammation, pain management, oncology, CNS conditions, diabetes, obesity, and cardiovascular diseases. Technological advancements, such as genomics, AI, IoT, real-world data, patient-centric trials, virtual trials, home healthcare services, digitalization, and electronic data capture, are transforming the landscape. The industry is in a growth stage, with a high demand for CRO services, decentralized trials, telemedicine, and advanced therapies. The European Medicines Agency and regulatory bodies play a crucial role in post-marketing surveillance. The degree of innovation is high, with a focus on personalized medicine, R&D programs, outsourcing activities, and patent expiration. Key trends include the use of interventional studies, expanded access trials, compassionate use trials, and the evolution of traditional clinical trials towards more decentralized and virtual models. Companies like Parexel, Syneos Health, Thermo Fisher Scientific, and CorEvitas, LLC are at the forefront of these developments. 1 Executive Summary 2 Market Landscape 3 Market Sizing 4 Historic Market Size 5 Five Forces Analysis 6 Market Segmentation Type Phase III Phase I Phase II Phase IV Service Type Interventional Studies Observational Studies Expanded Access Studies Indication Oncology CNS Autoimmune/inflammation Others Geography North America 7 Customer Landscape 8 Geographic Landscape 9 Drivers, Challenges, and Trends 10 Company Landscape 11 Company Analysis 12 Appendix Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios. Technavio Research Jesse Maida Media & Marketing Executive US: +1 844 364 1100 UK: +44 203 893 3200 Email: [email protected] Website: www.technavio.com/ SOURCE TechnavioSAN DIEGO, Dec. 17, 2024 (GLOBE NEWSWIRE) -- LPL Financial LLC ("LPL Financial”), a wholly owned subsidiary of LPL Financial Holdings Inc. ( Nasdaq: LPLA ) (the "Company”), today released its monthly activity report for November 2024. Total advisory and brokerage assets at the end of November were $1.76 trillion, an increase of $86.0 billion, or 5.1%, compared to the end of October 2024. Total net new assets for November were $35.0 billion, which included $0.8 billion of acquired net new assets resulting from Liquidity & Succession activity. Total organic net new assets for November were $34.2 billion, translating to a 25.9% annualized growth rate. This included $26.3 billion of assets from Prudential Advisors ("Prudential”) that onboarded in November, and $0.6 billion of assets that off-boarded as part of the previously disclosed planned separation from misaligned large OSJs. Prior to these impacts, organic net new assets were $8.6 billion, translating to a 6.5% annualized growth rate. Total organic net new advisory assets were $27.9 billion, translating to a 37.6% annualized growth rate. Excluding the assets onboarded from Prudential and the off-boarded assets from misaligned large OSJs, total organic net new advisory assets were $9.6 billion, translating to a 12.9% annualized growth rate. Total client cash balances at the end of November were $50.5 billion, an increase of $2.2 billion compared to the end of October 2024. This included $1.9 billion resulting from the onboarding of Prudential. Net buying in November was $12.4 billion. For additional information regarding these and other LPL Financial business metrics, please refer to the Company's most recent earnings announcement , which is available in the quarterly results section of investor.lpl.com . Contacts Investor Relations [email protected] Media Relations [email protected] About LPL Financial LPL Financial Holdings Inc. (Nasdaq: LPLA) is among the fastest growing wealth management firms in the U.S. As a leader in the financial advisor-mediated marketplace, LPL supports more than 28,000 financial advisors and the wealth management practices of approximately 1,200 financial institutions, servicing and custodying approximately $1.8 trillion in brokerage and advisory assets on behalf of approximately 6 million Americans. The firm provides a wide range of advisor affiliation models, investment solutions, fintech tools and practice management services, ensuring that advisors and institutions have the flexibility to choose the business model, services, and technology resources they need to run thriving businesses. For further information about LPL, please visit www.lpl.com . Securities and Advisory services offered through LPL Financial LLC ("LPL Financial”), a registered investment advisor. Member FINRA/SIPC. LPL Financial and its affiliated companies provide financial services only from the United States. Throughout this communication, the terms "financial advisors” and "advisors” are used to refer to registered representatives and/or investment advisor representatives affiliated with LPL Financial. We routinely disclose information that may be important to shareholders in the " Investor Relations ” or " Press Releases ” section of our website.
UCF, LSU face off with improved focus in mindUCF will attempt to shake off a dreadful offensive performance when it collides with LSU on Sunday afternoon in the third-place game of the Greenbrier Tip-Off in White Sulphur Springs, W.Va. The Knights (4-1) couldn't get anything going against No. 19 Wisconsin on Friday, going 21-for-62 from the field (33.9 percent) and just 2-for-17 from 3-point range (11.8 percent) en route to an 86-70 loss. Jordan Ivy-Curry finished with 13 points while Keyshawn Hall and Dior Johnson added 11 apiece for UCF, which never led and fell behind by as many as 23. Knights coach Johnny Dawkins is hoping that his team's struggles don't carry over into the meeting with the Tigers (4-1). "We have to do better offensively," Dawkins said. "We have to space the floor better. We have to balance our offense between our perimeter and our bigs. Those are things that we didn't do consistently (on Friday)." LSU also needs to clean things up after committing 15 turnovers in a 74-63 setback against Pitt on Friday. Tigers forward Jalen Reed doesn't believe giving the ball away will be a lingering issue. "I feel like a lot of our turnovers were more on us than them," Reed said. "I feel like a lot of the turnovers were careless, but we're a better team than that and I feel like we'll take care of the ball better moving forward." Reed and Vyctorius Miller each posted 14 points in the loss to the Panthers, with Reed also hauling in seven rebounds. Cam Carter chipped in 11 points. Carter is putting up a team-leading 16.4 points per game. Jordan Sears (12.0 points per game), Reed (11.0) and Miller (10.2) also have scoring averages in double figures. Ivy-Curry (16.8 points per game), Hall (16.2) and Darius Johnson (13.0) have been leading the way for UCF. Sunday marks the first-ever meeting between the Knights and Tigers. --Field Level Media
Geode Capital Management LLC lifted its holdings in AMERISAFE, Inc. ( NASDAQ:AMSF – Free Report ) by 1.4% in the third quarter, HoldingsChannel reports. The firm owned 453,539 shares of the insurance provider’s stock after purchasing an additional 6,166 shares during the quarter. Geode Capital Management LLC’s holdings in AMERISAFE were worth $21,924,000 at the end of the most recent reporting period. Other institutional investors and hedge funds have also recently modified their holdings of the company. Public Employees Retirement Association of Colorado grew its holdings in shares of AMERISAFE by 5.1% in the second quarter. Public Employees Retirement Association of Colorado now owns 315,409 shares of the insurance provider’s stock valued at $13,843,000 after purchasing an additional 15,196 shares in the last quarter. State Street Corp grew its holdings in shares of AMERISAFE by 8.5% in the third quarter. State Street Corp now owns 811,561 shares of the insurance provider’s stock valued at $39,223,000 after purchasing an additional 63,638 shares in the last quarter. Jane Street Group LLC grew its holdings in shares of AMERISAFE by 70.6% in the third quarter. Jane Street Group LLC now owns 41,299 shares of the insurance provider’s stock valued at $1,996,000 after purchasing an additional 17,084 shares in the last quarter. Intech Investment Management LLC bought a new stake in AMERISAFE in the second quarter worth $591,000. Finally, BNP Paribas Financial Markets boosted its stake in AMERISAFE by 6.9% during the third quarter. BNP Paribas Financial Markets now owns 5,882 shares of the insurance provider’s stock worth $284,000 after buying an additional 381 shares during the period. 97.41% of the stock is owned by hedge funds and other institutional investors. Wall Street Analyst Weigh In A number of research analysts have weighed in on AMSF shares. Truist Financial boosted their price objective on shares of AMERISAFE from $48.00 to $54.00 and gave the company a “hold” rating in a research report on Friday, October 25th. JMP Securities reissued a “market outperform” rating and issued a $65.00 price objective on shares of AMERISAFE in a research note on Tuesday, October 15th. AMERISAFE Price Performance Shares of NASDAQ AMSF opened at $51.63 on Friday. The company has a market cap of $983.55 million, a P/E ratio of 16.13 and a beta of 0.33. AMERISAFE, Inc. has a 1 year low of $41.97 and a 1 year high of $60.24. The firm has a 50-day simple moving average of $55.60 and a two-hundred day simple moving average of $50.08. AMERISAFE ( NASDAQ:AMSF – Get Free Report ) last announced its quarterly earnings data on Wednesday, October 23rd. The insurance provider reported $0.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.56 by $0.02. The business had revenue of $78.70 million during the quarter, compared to the consensus estimate of $75.38 million. AMERISAFE had a net margin of 19.49% and a return on equity of 16.50%. During the same quarter last year, the firm earned $0.61 earnings per share. As a group, equities research analysts expect that AMERISAFE, Inc. will post 2.45 EPS for the current year. AMERISAFE Increases Dividend The company also recently disclosed a quarterly dividend, which was paid on Friday, December 13th. Shareholders of record on Friday, December 6th were paid a $3.37 dividend. The ex-dividend date was Friday, December 6th. This represents a $13.48 annualized dividend and a yield of 26.11%. This is an increase from AMERISAFE’s previous quarterly dividend of $0.37. AMERISAFE’s dividend payout ratio (DPR) is presently 46.25%. AMERISAFE Company Profile ( Free Report ) AMERISAFE, Inc, an insurance holding company, underwrites workers’ compensation insurance in the United States. The company provides benefits to injured employees for temporary or permanent disability, death, and medical and hospital expenses. It sells its products through retail and wholesale brokers and agents; and small and mid-sized employers engaged in hazardous industries, including construction, trucking, logging and lumber, agriculture, manufacturing, telecommunications, and maritime. Further Reading Want to see what other hedge funds are holding AMSF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AMERISAFE, Inc. ( NASDAQ:AMSF – Free Report ). Receive News & Ratings for AMERISAFE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMERISAFE and related companies with MarketBeat.com's FREE daily email newsletter .SAN DIEGO , Dec. 5, 2024 /PRNewswire/ -- BSD Builders, Inc. today announced it has received seismic certification from California's OSHPD/HCAi for its state-of-the-art Microgrid Solutions. Developed in partnership with 2G Energy Inc., the BSD Special Seismically Certified (SSC) Microgrid product is set to revolutionize energy resilience and efficiency for all types of buildings. The BSD SSC Microgrid system, consisting of a cogeneration power plant and fuel storage, was initially designed to support California skilled nursing facilities' compliance with California Assembly Bill 2511, which California Governor Gavin Newsom signed into law on September 29, 2022 . This bill requires these facilities to have an alternative power source to protect resident health and safety for at least 96 hours during any type of power outage. This microgrid power solution is a self-contained electrical system that can operate independently from the main power grid. With the seismic certification, it is now available for any type of building that needs uninterruptable power. "At BSD Builders, we're passionate about creating solutions that make a difference in people's lives. We have developed a proprietary solution that not only meets but exceeds California's stringent seismic requirements while providing a reliable and efficient source of power, especially during unexpected power loss or natural disasters," said Jeff Blair , CEO of BSD Builders, Inc. "This solution offers long-term benefits not only by lowering utility costs, it can also help to improve the stability of the regional electric grid and reduce carbon emissions." Key features of the BSD SSC Microgrid Solution include: "2G Energy is proud to partner with BSD on the BSD SSC Microgrid System designing it for a wide range of applications, providing a reliable and cost-effective energy solution for skilled nursing facilities, hospitals, data centers, pharmaceutical labs, research facilities, cold storage units, data centers, and more," stated Darren Jamison , Managing Director of 2G Energy North America. "The design utilizes proprietary technologies to offer clients reduced utility costs and increased reliability. It is designed for continuous parallel operation with the utility as well as stand-alone island mode," concluded Jamison. For more information about the BSD SSC Microgrid System or to schedule a consultation, please visit bsdbuilders.com . About BSD Builders, Inc . - BSD Builders, Inc. is a leading general contractor specializing in the healthcare industry. Focusing on exceeding industry standards and delivering exceptional value to clients, BSD Builders, Inc. continues to set the benchmark for excellence in the construction and energy sectors. About 2G Energy – 2G Energy is a globally recognized leader in the development and production of combined heat and power (CHP) systems. With a commitment to sustainability and innovation, 2G Energy provides cutting-edge solutions that optimize energy efficiency and environmental performance. View original content to download multimedia: https://www.prnewswire.com/news-releases/bsd-builders-inc-advanced-microgrid-solutions-receives-california-seismic-certification-for-uninterruptible-power-supply-302324334.html SOURCE BSD Builders, Inc.
Vance takes on a more visible transition role, working to boost Trump’s most contentious picks
Montana transgender lawmaker on Capitol Hill's bathroom ban: 'Do not cede ground'Trend Vision OneTM – Email and Collaboration Security is a critical part of Trend's centralized attack surface risk management (ASRM) platform DALLAS , Dec. 17, 2024 /PRNewswire/ -- Trend Micro Incorporated ( TYO: 4704 ; TSE: 4704 ), a global cybersecurity leader, today announced its positioning as a Leader in the 2024 Gartner® Magic QuadrantTM for Email Security Platforms (ESP) . Rachel Jin , Chief Enterprise Platform Officer at Trend: "While technology continues to evolve, email remains the number one form of business communication—and a critical threat vector. Centralizing visibility and control as part of a fully integrated security architecture enables our customers to accelerate compliance and mitigate risk." Trend's flagship ESP product, Trend Vision OneTM – Email and Collaboration Security, is seamlessly integrated as part of a comprehensive ASRM and XDR platform for correlated intelligence and enhanced cross-layer security delivered from a single source. According to Gartner, "Leaders have a strong vision for the future of ESPs, balanced with the Ability to Execute on those visions. While Leaders may vary in product efficacy or functionality, their services offered are consumable by broad swathes of the email market and have strong commitments to customer success. Leaders are early to identify new attack trends and move quickly to fill gaps created by an evolving threat landscape, either by innovation or acquisition. Leaders excel with technical capabilities, infrastructure that supports progressive product strategies, and an emphasis on customer success." Trend has always prioritized continuous customer feedback, starting early on in the development lifecycle, in order to drive innovation, generate new product ideas and align solutions with user expectations. Core capabilities of Trend's ESP include: Trend's sales strategy is built on deep industry expertise and extensive intelligence. This enables the company to anticipate and rapidly respond to market shifts. *Gartner, Magic Quadrant for Email Security Platforms, By Max Taggett , Nikul Patel , Franz Hinner , Deepak Mishra , 16 December 2024 Gartner does not endorse any vendor, product or service depicted in its research publications and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner's Research & Advisory organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose. GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally, Magic Quadrant is a registered trademark of Gartner, Inc. and/or its affiliates and is used herein with permission. All rights reserved. About Trend Micro Trend Micro, a global cybersecurity leader, helps make the world safe for exchanging digital information. Fueled by decades of security expertise, global threat research, and continuous innovation, Trend Micro's AI-powered cybersecurity platform protects hundreds of thousands of organizations and millions of individuals across clouds, networks, devices, and endpoints. As a leader in cloud and enterprise cybersecurity, Trend's platform delivers a powerful range of advanced threat defense techniques optimized for environments like AWS, Microsoft, and Google, and central visibility for better, faster detection and response. With 7,000 employees across 70 countries, Trend Micro enables organizations to simplify and secure their connected world. www.TrendMicro.com . View original content to download multimedia: https://www.prnewswire.com/news-releases/trend-micro-named-a-magic-quadrant-leader-for-email-security-platforms-302334254.html SOURCE Trend Micro Incorporated
SAN FRANCISCO , Dec. 5, 2024 /PRNewswire/ -- Silicon Valley's seasoned veterans in retail and e-commerce are rallying behind Jingo , a bold leap forward in transforming the online shopping experience. By blending personalization with advanced technology, Jingo is rethinking the way shoppers discover products and how brands connect with their audiences. A Powerhouse Backing Founded by e-commerce veterans, Ujjal Pathak and Rohan Bhanot , who bring years of experience building online shopping platforms, Jingo has secured backing from a powerhouse group of investors and advisors with expertise from leading companies such as Pinterest, Walmart, Minted, eBay, Square, Nike, Klarna, and Intuit. Their collective knowledge in e-commerce, retail, and fintech provides the strategic guidance needed to bring Jingo's vision of a smarter, more equitable shopping platform to life. Solving the Real Problem in E-Commerce Amazon has been shaping online shopping for nearly 30 years, while Walmart has stood as a retail giant for over 60. While these platforms revolutionized e-commerce for past generations, Jingo is built from the ground up to meet the needs of today's digitally native consumers. Designed with Gen Z and Millennials in mind, Jingo delivers a shopping experience that feels intuitive, personal, and deeply connected to modern lifestyles. For customers, the challenge isn't simply finding products—it's making better decisions . Endless choices often lead to decision fatigue and frustration. Jingo tackles this by prioritizing relevance over sheer quantity. Using machine learning, the platform curates and presents personalized assortments early in the shopping journey, showing the most relevant products at the right time. This thoughtful approach fosters confidence and transforms decision-making into an enjoyable process. For brands and sellers, major marketplace platforms often tie visibility to significant advertising spend, creating barriers for smaller players. Jingo flips this model by leveraging advanced machine learning to surface products only to customers with genuine interest. This precision eliminates waste, reduces noise, and ensures that every connection between brands and customers feels meaningful. Empowered by tools like real-time insights, predictive analytics, and curated discovery, brands can optimize inventory, anticipate trends, and connect with their ideal audience without relying on costly campaigns or third-party tools. Jingo is creating a marketplace where both customers and sellers thrive, redefining how value is delivered in online shopping. A Transformative Vision for the Future Jingo's ambitions go far beyond optimizing today's online shopping experience. The platform is building toward a future where commerce is redefined through intelligent systems that seamlessly integrate into users' lives. Imagine a world where shopping evolves from a process you initiate to an experience that happens intuitively. Jingo's end-state vision is to create intelligent systems capable of learning, adapting, and acting on behalf of users , delivering personalized, proactive, and effortless commerce. This approach points to a future where products appear at your doorstep before you even think about shopping, making commerce an invisible yet integral part of daily life. By designing systems that dynamically adapt and provide proactive support, Jingo aims to fundamentally change the way consumers and brands interact, setting a new standard for convenience, personalization, and connection. Flipping the Script for Brands and Sellers Beyond offering better targeting, Jingo is reimagining the commission structure to create a fairer and more seller-focused marketplace. For the first 1,000 brands and sellers who join, Jingo introduces a groundbreaking model: These incentives, coupled with Jingo's advanced tools like predictive analytics and real-time insights, empower sellers to focus on delivering quality products while Jingo ensures they reach the right customers. By reducing the noise-to-signal ratio, brands can build lasting, loyalty-driven relationships in a transparent and equitable ecosystem. Brands and sellers interested in being part of this transformative journey can contact the Jingo team at partner@jingo.app A Bold Vision for E-Commerce With the support of Silicon Valley's leading minds, Jingo is setting a new benchmark for what online shopping can achieve. By addressing decision-making challenges for consumers and creating deeper, more equitable connections for brands, Jingo is leading the next wave of e-commerce innovation. To celebrate its launch, Jingo is running a referral campaign from December 6, 2024 , to February 28, 2025 . Participants can earn credits to shop on the platform once it's live, with prizes of $50,000 for the top referrer, $30,000 for second place, and $10,000 for third. Jingo is more than a platform—it's a movement toward smarter, more personalized, and intuitive commerce. By building systems that anticipate, simplify, and deliver, Jingo is shaping the future of shopping for consumers and sellers alike. Get in Touch For PR inquiries, strategic partnerships, or more information, contact contact@jingo.app View original content to download multimedia: https://www.prnewswire.com/news-releases/redefining-the-future-of-shopping-jingo-gains-silicon-valleys-backing-302324337.html SOURCE Jingo Technologies, Inc.Barcelona, which has already taken action to stop the spread of holiday rental apartments, is the latest Spanish city to see protests for cheaper housing. Backed by left-wing parties and unions, the demonstrators gathered in central Barcelona behind a giant banner declaring "Lower the rents". "Today a new political cycle starts concerning housing," Carme Arcarazo, spokesperson for the Catalan Tenants Union, the main organiser, told reporters. "Investors must not be allowed to come to our cities and play with the apartments like a game of Monopoly," she added. The union would target "profiteers" who are taking "half of our salaries", Arcarazo said. The demonstrators demanded a 50 percent cut in rents, leases with an unlimited term and a ban on "speculative" sales of buildings. They threatened to start a rent strike. An estimated 22,000 people took part in a similar demonstration in Madrid on October 13. Campaigns have been launched in other cities. According to the Idealista specialised website, rental prices per square metre have risen 82 percent across Spain over the past decade. The average salary has gone up by 17 percent in that time, according to the national statistics institute. Facing pressure over a housing crisis, the government in 2023 passed legislation calling for more social housing, greater restrictions on rents in high demand areas and penalties for owners who do not occupy properties. But rents have continued to rise while the government has battled city and regional authorities to get some parts of the law applied. vid-vab/tw/jm
Total number of Texas fans caught and punished for throwing bottles in Georgia game: ZeroRep. Tom Tiffany Torches Biden Official 'Proud' of Border Policies: 'You Have Been Part of Largest Human Trafficking Operation Since Slavery'‘Matt and Mara’ Review: Two Writers Rekindle Their College Bond In a Subtly Slippery Relationship DramaThe Russian government has approved a ban on mobile and landline connections via the Internet. Source : Russian government decree Details : The Russian government has removed "transmission of Internet data with voice information" from the list of licensed communication services, effectively banning calls over the Internet by mobile and landline phones. Russia claims the ban is aimed at combating fraud. "Most often, fraudsters used such technologies, as it allowed them to switch phone numbers. This type of telephone fraud will be significantly restricted, as connecting data networks to telephone networks will no longer be possible," the Russian government said in a statement. Background: Support UP or become our patron !
Republicans rally around Hegseth, Trump’s Pentagon pick, as Gaetz withdraws for attorney generalMILWAUKEE — Giannis Antetokounmpo had 32 points and 11 rebounds and Damian Lillard added 31 points to lead the Milwaukee Bucks past the Charlotte Hornets 125-119 on Saturday night for their fourth consecutive victory. Milwaukee opened the fourth quarter with a 14-5 spurt for a 110-90 lead, but the Hornets got it to 121-119 on Brandon Miller’s 3-pointer with 15 seconds left. Taurean Prince answered with a pair of free throws for the Bucks to make it a two-possession game, and Charlotte missed a pair of 3-pointers on the ensuing possession. Antetokounmpo hit two free throws with 4.5 seconds left to make it 125-119. LaMelo Ball had a career-high 50 points for the Hornets, and Brandon Miller added 32. Ball hit 17 of 38 shots, including 6 of 17 beyond the arc, and 10 of 13 free throws. Milwaukee, which completed a 4-0 homestand, has won six of its last seven. The only loss in that span was a 115-114 loss to the Hornets on Nov. 16 following a controversial foul call. Charlotte’s Grant Williams went to the locker room late in the fourth quarter with an apparent leg injury and did not return. Takeaways Hornets: Charlotte has lost five of its last seven. Milwaukee Bucks' Bobby Portis reacts in front of Charlotte Hornets' LaMelo Ball during the second half of an NBA basketball game Saturday, Nov. 23, 2024, in Milwaukee. The Bucks won 125-119. Credit: AP/Morry Gash Bucks: Lillard, who did not play in the Bucks' last game against Charlotte, hit 9 of 21 shots, including 10 of 11 free throws. Key moment Milwaukee hit four consecutive 3-pointers for a 12-3 run and a 96-83 lead late in the third quarter. Key stat The Bucks were 18 of 37 from beyond the arc, matching their season high in 3-pointers made. Up next The Hornets host the Orlando Magic on Monday, and the Bucks are at the Miami Heat in NBA Group Play on Tuesday.
‘Sharks’ vet pitches from entrepreneurs at FAU. See who scored a dealNone
Simon Harris says sorry to Cork carer for ‘not giving her the time she deserved’